Altamira Therapeutics Ltd. (CYTO) has a market capitalization of $1.13M and trades at $0.30. The 52-week range is 0.3-0.4158.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0, Earnings Per Share (EPS) of $-14.81.
The stock has a beta of 2.44, operates in the Healthcare sector.
